Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT)
NCT07281950
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Dry Eye Disease (DED)
Interventions
DRUG:
acoltremon 0.003%
Sponsor
Center for Sight Las Vegas